In Spain, patients with neuroimmune diseases such as fibromyalgia or myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) have been disgusted at their government’s refusal to recognize them as seriously disabled human beings. This week brought news of a big step forward.
By Eric Pyrrhus
In 2019 the Spanish government agency that oversees disability pensions, the National Institute for Social Security (INSS), issued new guidelines for evaluating the disability of people living with neuroimmune diseases such as fibromyalgia or ME/CFS. Soon after, Dr. Joaquím Fernández Solà, a professor of medicine at the University of Barcelona, issued a strongly worded letter condemning the new guide:
I consider that this guide does not meet the minimum criteria of scientific consistency, is not created by any panel of experts on the subject, […] is not based on proven scientific evidence, does not contemplate the principal physiopathological bases of these illnesses, contrasts with previously established protocols, and contains many unsubstantiated claims that can be prejudicial for patients affected by these illnesses. […] Because of all this, I propose that the guide be annulled in its entirety.
– Dr. Joaquím Fernández Solà
A coalition of patient groups in Spain, CONFESQ, immediately started a petition to retract the guide. CONFESQ noted that the new guide would be distributed to all primary care physicians in the country and would determine whether patients with neuroimmune conditions could receive their proper disability pensions. The petition has gathered almost 30,000 signatures to date.
What was the most important objection in the petition? Point number one in the petition states that “the inclusion of Somatoform Disorder among the diseases actually covered by the guidelines has no medical or scientific justification. This disorder in fact acts as a filter, veiled or explicitly denying the reality of these diseases as organic pathologies and entities of their own, ignoring the current scientific evidence.”
The stakes are indeed high. According to a 2019 scientific study which looked at over 1000 Spanish ME/CFS patients, 59% of patients with ME/CFS were unemployed and patients with worse symptoms were much more likely to be unemployed than those with minor symptoms. Fibromyalgia was found in 62% of the unemployed, but only 46% of the employed.
How many unemployed patients with a neuroimmune disease successfully receive a disability pension?
According to a 2020 survey of over 700 Spanish patients who had applied for a disability pension, only about 30% of those patients successfully received a permanent disability pension, after an evaluation process which sometimes could last 2-5 years.
Many had to continue working throughout this evaluation process. Over half of those patients that received a disability pension were forced to take their case to the courts in order to be successful.
New urgency, new proposals
According to a 2020 press release issued by CONFESQ, the coalition of patient groups, the Spanish government agency initially agreed to meet with the patient groups.
In response to the petition, the government agency agreed to remove a chapter on Somatoform Disorder and to conduct a review of the guide’s contents by a committee of experts. However, to date, this review by a committee of experts has not occurred.
And in a 2021 press release, CONFESQ stated that it had repeatedly requested a follow-up meeting, but had not received any response to these requests from INSS, the Spanish government agency that oversees disability pensions.
In the two press releases, CONFESQ argued that there were three reasons why it was even more urgent to quickly correct the inadequacies of the INSS guidelines:
- First, the COVID-19 pandemic could possibly lead to a surge of new patients.
- Second, the European Parliament approved a resolution in June 2020 requesting additional funding for research into ME/CFS — a resolution which recognized that the current lack of understanding seriously hinders the proper recognition of patients’ inability to work.
Third, the Health Commission of the Spanish Congress of Deputies approved a resolution in September 2020 which urges INSS to establish clear guidelines on neuroimmune diseases, not as psychological disorders or with psychosomatic symptoms, but as real and objectifiable diseases.
In an initial meeting with patients, INSS had asked the patient groups to argue and substantiate point-by-point the aspects in disagreement from the 2019 guidelines.
So the coalition of patient groups, along with Dr. Joaquím Fernández Solà and other informed doctors, put together their own thorough and exhaustive scientific analyses, including one on ME/CFS, one on fibromyalgia, and one on the gender bias implicit in the INSS guidelines.
“How much longer must we bear this mistreatment by the INSS?” asks Carmen Torija Carpintero, a patient from Madrid with ME/CFS and fibromyalgia. “Here there is an extremely serious inequality, and we are almost all women who have been harmed! As a Spaniard, I feel unprotected!”
The last resort
What do you do when the government refuses to recognize your existence as a seriously disabled human being? Take them to court?
It is a harsh reality that we are living: patients are forced to go to court to have their permanent work disability recognized outside the administrative process, with serious consequences for their health and their finances.
– María López Matallana, vice-president of CONFESQ
Recent news reports describe how some Spanish patients have successfully been granted full disability pensions by the courts, including a professor from Zamora, a shopkeeper, teacher, and nursing assistant in Andalusia, a business assistant, domestic employee, and administrative assistant in Catalonia, and a nursing assistant in Asturias.
But these recent news reports may not signal a new trend.
“This has been happening for at least two decades, [but] these days a better knowledge of the diseases, more accurate tests of dysfunction, and [a specialization by some lawyers] is allowing some of the cases that are winning in court to be known” advises María López Matallana, vice-president of CONFESQ.
Legal experts seem to agree. “These are individual cases, like many others that are not published, but which coexist in time with many others whose disability is not recognized. The judicial struggle is individual and does not involve previous cases,” clarifies Ángel García of the legal advocacy organization Fibromialgia Jurídica.
“In my opinion, it continues to be complicated to obtain permanent disability benefits in relation to this group of diseases,” asserts Vicente Javier Saiz Marco, a legal expert in work disability related to neuroimmune diseases.
“It is true that there has been a significant increase in the number of favorable rulings but, if we establish an overall assessment between those that are upheld and those that are rejected, there continues to be a greater number of the latter.”
Patient advocates are left in a quandary. Is the current situation simply the case of a stingy government bureaucracy? Is the solution to be found through the courts? Or is there a more fundamental problem at play?
Legal expert Vicente Javier Saiz Marco provides a blunt answer to these questions: “In my judgment, the problem is rooted in the lack of consensus in the medical community on the [true] impact of the functional limitations derived from these diseases.”
Finally, a big win
This week brought surprising news to a weary community of patients. CONFESQ announced that it had finally received confirmation from the director general of INSS that the 2019 work disability guide had been definitively withdrawn.
“We are thrilled, as we suppose the whole community will be, and although much work remains to be done, and this withdrawal will probably not mean that the disability assessments will be as we would like them to be, at least this tremendously biased and harmful guide for patients is no longer accessible and cannot be used as a reference in medical reports, nor in the courts.”
The fight continues! Check out a petition from Mexico that similarly seeks recognition of work disability for patients: Let’s recognize fibromyalgia as a disabling disease
Eric Pyrrhus is a scientist with an interest in flaviviruses, coronaviruses, and imaging technology. With undergraduate training at Columbia University and the University of Pennsylvania, and graduate training at U.C. Berkeley and UCSF Medical School, he has studied biomedical sciences, bioinformatics, biomedical imaging, biosensors, computer science, artificial intelligence, and business administration.